|
ZNF526 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.206000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.595800E-04 |
| Normal-vs-Stage2 |
7.495900E-03 |
| Normal-vs-Stage3 |
1.140920E-03 |
| Normal-vs-Stage4 |
2.813800E-04 |
| Stage1-vs-Stage2 |
7.324200E-01 |
| Stage1-vs-Stage3 |
6.655600E-01 |
| Stage1-vs-Stage4 |
4.695000E-01 |
| Stage2-vs-Stage3 |
9.904000E-01 |
| Stage2-vs-Stage4 |
4.033600E-01 |
| Stage3-vs-Stage4 |
3.221400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.807700E-04 |
| Normal-vs-AfricanAmerican |
8.484300E-02 |
| Normal-vs-Asian |
6.777700E-03 |
| Caucasian-vs-AfricanAmerican |
4.311600E-01 |
| Caucasian-vs-Asian |
4.464200E-01 |
| AfricanAmerican-vs-Asian |
7.477800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.704300E-03 |
| Normal-vs-Female |
2.167300E-04 |
| Male-vs-Female |
1.571230E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.620500E-04 |
| Normal-vs-Age(41-60Yrs) |
7.602300E-04 |
| Normal-vs-Age(61-80Yrs) |
6.558500E-04 |
| Normal-vs-Age(81-100Yrs) |
7.886600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.530800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.726200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.675200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.600000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.937800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.661800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.042040E-01 |
| Classical-VS-Follicular |
8.898800E-03 |
| Classical-VS-Other |
5.273200E-01 |
| Classical-VS-Normal |
2.895900E-03 |
| Tall-VS-Follicular |
9.064200E-01 |
| Tall-VS-Other |
9.085000E-01 |
| Tall-VS-Normal |
2.020900E-04 |
| Follicular-VS-Other |
9.115000E-01 |
| Follicular-VS-Normal |
5.84399999999929E-05 |
| Other-VS-Normal |
7.092000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.335200E-03 |
| Normal-vs-N1 |
5.70559999999443E-05 |
| N0-vs-N1 |
5.239600E-02 |
|
|
